The underlying mechanism responsible for this cooperative effect of Aβ and tau is not clear at this time, but the new finding provides further support for targeting tau as a potential therapeutic approach in treating AD and possibly relevant mood disorders. The gene discussed is MAPT; the disease is Alzheimer disease.